Related Experiment Video
Updated: Jun 14, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely
David Snipelisky1, Jerry D Estep1
1Robert and Suzanne Tomsich Department of Cardiology, Section of Heart Failure & Cardiac Transplant Medicine, Cleveland Clinic, 2950 Cleveland Clinic Boulevard, Weston, FL 33331, USA.
Heart Failure Clinics
|August 31, 2024
Summary
Cardiogenic shock is a serious condition with high mortality. Selecting the right temporary mechanical circulatory support device based on patient hemodynamics is crucial for effective treatment.
Area of Science:
- Cardiology
- Critical Care Medicine
- Hemodynamics
Background:
- Cardiogenic shock (CS) is a severe condition with high mortality.
- Initial treatments involve vasopressors and inotropes, which can worsen outcomes.
- Refractory CS may necessitate mechanical circulatory support.
Purpose of the Study:
- To review the role of temporary mechanical circulatory support in CS.
- To emphasize the importance of hemodynamic profiling in device selection.
- To highlight the need for a multidisciplinary approach in CS management.
Main Methods:
- Literature review of CS pharmacotherapies and mechanical support devices.
- Analysis of hemodynamic principles relevant to CS phenotypes.
- Discussion of patient selection criteria for mechanical support.
Main Results:
- Pharmacotherapies can increase myocardial oxygen demand and decrease perfusion.
- Temporary mechanical circulatory support offers various hemodynamic strategies.
- No single device is universally optimal; patient-specific selection is key.
Conclusions:
- Understanding patient hemodynamics and CS phenotype guides device choice.
- Careful patient selection is paramount for successful mechanical support.
- A multidisciplinary team approach improves outcomes in CS management.
